Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Myriad Genetics Inc
(NQ:
MYGN
)
28.29
-0.18 (-0.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Myriad Genetics Inc
< Previous
1
2
3
4
Next >
Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Showcasing Advancements in Breast Cancer Risk Assessment and Treatment
November 29, 2022
From
Myriad Genetics, Inc.
Via
GlobeNewswire
GeneSight Mental Health Monitor Reveals Gap on the Front Line of Mental Health Care
November 17, 2022
Survey finds primary care providers wish patients would raise mental health concerns so they can provide better overall care
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Focuses on Expanding Access, Collaboration and Equity in Genetic Testing at National Society of Genetic Counselors Meeting
November 14, 2022
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Announces UroSuite™, an Industry-First Suite of Genetic Tests for Prostate Cancer, Giving Urologists Access to Timely, Data-driven Medical Information
November 10, 2022
From
Myriad Genetics, Inc.
Via
GlobeNewswire
New Study Published in JCO Precision Oncology Features Data Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries
November 03, 2022
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test
November 01, 2022
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Reports Third Quarter Financial Results
November 01, 2022
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Expands Board of Directors with Election of Paul M. Bisaro as New Board Member
October 31, 2022
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics to Release Third-Quarter Financial Results on Nov. 1, 2022
October 26, 2022
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Is Illumina Still the Gamechanger in Genomics Sequencing?
October 04, 2022
Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused
Via
MarketBeat
Topics
Earnings
Economy
Lawsuit
Exposures
Financial
Legal
Supply Chain
Family Cancer History Still a Mystery to Many Women, Myriad Genetics Survey Finds
September 28, 2022
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics to Release 2022 Second-Quarter Financial Results on Aug. 4, 2022
July 28, 2022
From
Myriad Genetics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.